Haris Ali

Haris Ali

Beckman Research Institute of City of Hope - California / United States
Medical and Health Sciences / Hematology
AD Scientific Index ID: 4607927
City of Hope National Medical Center
person_outline Haris Ali's MOST POPULAR ARTICLES
1-) Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial Blood, The Journal of the American Society of Hematology 135 (20), 1739-1749, 2020
2-) Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia Haematologica 103 (9), e404, 2018
3-) Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia Nature medicine 24 (4), 450-462, 2018
4-) Myeloproliferative neoplasms, version 3.2022, NCCN clinical practice guidelines in oncology Journal of the National Comprehensive Cancer Network 20 (9), 1033-1062, 2022
5-) Phase I trial of total marrow and lymphoid irradiation transplantation conditioning in patients with relapsed/refractory acute leukemia Biology of Blood and Marrow transplantation 23 (4), 618-624, 2017